看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Quest Diagnostics Incorporated |
| Cryo-Cell International, Inc. |
| Guardant Health, Inc. |
| OPKO Health, Inc. |
| Precipio, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| DGX | CCEL | GH | OPK | PRPO | N6B | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 14% | 1% | 456% | -3% | -25% | 9% | ||
| Fiscal Year - 1 | 14% | 152% | -438% | -13% | -38% | 4% | ||
| Fiscal Year - 2 | 15% | 208% | -186% | -20% | -60% | 10% | ||
| Fiscal Year - 3 | 30% | 274% | -42% | -2% | -44% | 22% | ||
| Fiscal Year - 4 | 23% | -75% | -24% | 2% | -102% | 18% | ||
| Fiscal Year - 5 | 15% | -29% | -12% | -18% | -137% | 11% | ||
| Average | 19% | 89% | -41% | -9% | -68% | 13% | ||
| Median | 15% | 76% | -33% | -8% | -52% | 11% | ||
| Benchmarks | Ticker | |||||||
| Quest Diagnostics Incorporated | NYSE:DGX | |||||||
| Cryo-Cell International, Inc. | NYSEAM:CCEL | |||||||
| Guardant Health, Inc. | NasdaqGS:GH | |||||||
| OPKO Health, Inc. | NasdaqGS:OPK | |||||||
| Precipio, Inc. | NasdaqCM:PRPO | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | DGX | CCEL | GH | OPK | PRPO | N6B | ||
| Latest Fiscal Year | Dec-24 | Nov-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Jun-25 | May-25 | Mar-25 | Mar-25 | Mar-25 | Jun-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 10,522 | 32 | 774 | 689 | 20 | 13,484 | ||
| Fiscal Year | 9,872 | 32 | 739 | 713 | 19 | 13,009 | ||
| Fiscal Year - 1 | 9,252 | 31 | 564 | 863 | 15 | 12,162 | ||
| Fiscal Year - 2 | 9,883 | 30 | 450 | 1,004 | 9 | 11,864 | ||
| Fiscal Year - 3 | 10,788 | 29 | 374 | 1,775 | 9 | 13,136 | ||
| Fiscal Year - 4 | 9,437 | 31 | 287 | 1,435 | 6 | 13,979 | ||
| Fiscal Year - 5 | 7,726 | 32 | 214 | 902 | 3 | 11,555 | ||
| Net Income | ||||||||
| Latest Twelve Months | 945 | (0) | (417) | (39) | (3) | 763 | ||
| Fiscal Year | 866 | 0 | (436) | (53) | (4) | 746 | ||
| Fiscal Year - 1 | 850 | (10) | (479) | (189) | (6) | 379 | ||
| Fiscal Year - 2 | 942 | 3 | (655) | (328) | (12) | 1,002 | ||
| Fiscal Year - 3 | 1,988 | 2 | (406) | (30) | (9) | 2,195 | ||
| Fiscal Year - 4 | 1,425 | 4 | (254) | 31 | (14) | 1,556 | ||
| Fiscal Year - 5 | 835 | 2 | (76) | (315) | (13) | 824 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 13,881 | 63 | 1,705 | 1,974 | 17 | 16,712 | ||
| Latest Fiscal Quarter | 15,969 | 64 | 1,344 | 2,128 | 18 | 18,060 | ||
| Fiscal Year | 16,153 | 65 | 1,486 | 2,200 | 17 | 18,379 | ||
| Fiscal Year - 1 | 14,022 | 61 | 1,786 | 2,012 | 18 | 16,725 | ||
| Fiscal Year - 2 | 12,837 | 65 | 1,610 | 2,167 | 22 | 20,155 | ||
| Fiscal Year - 3 | 13,611 | 61 | 2,204 | 2,400 | 30 | 20,385 | ||
| Fiscal Year - 4 | 14,026 | 46 | 2,272 | 2,473 | 21 | 20,072 | ||
| Fiscal Year - 5 | 12,843 | 43 | 963 | 2,309 | 20 | 18,046 | ||
| Fiscal Year - 6 | 11,003 | 42 | 587 | 2,451 | 22 | 16,185 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 6,617 | (11) | 68 | 1,253 | 13 | 8,006 | ||
| Latest Fiscal Quarter | 7,228 | (16) | (251) | 1,312 | 12 | 8,473 | ||
| Fiscal Year | 6,778 | (13) | (140) | 1,365 | 12 | 8,052 | ||
| Fiscal Year - 1 | 6,307 | (11) | 159 | 1,389 | 14 | 7,875 | ||
| Fiscal Year - 2 | 5,893 | (2) | 60 | 1,562 | 16 | 10,097 | ||
| Fiscal Year - 3 | 6,444 | 4 | 645 | 1,685 | 25 | 10,273 | ||
| Fiscal Year - 4 | 6,759 | (3) | 1,298 | 1,672 | 14 | 9,437 | ||
| Fiscal Year - 5 | 5,641 | (7) | 798 | 1,615 | 13 | 7,567 | ||
| Fiscal Year - 6 | 5,216 | (9) | 483 | 1,791 | 6 | 6,971 | ||